BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 18371527)

  • 1. Exploring the pathways between socioeconomic status and ESRD.
    Merkin SS
    Am J Kidney Dis; 2008 Apr; 51(4):539-41. PubMed ID: 18371527
    [No Abstract]   [Full Text] [Related]  

  • 2. Socioeconomic status and the incidence of ESRD.
    Ward MM
    Am J Kidney Dis; 2008 Apr; 51(4):563-72. PubMed ID: 18371532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISP: opening a new frontier in the diagnosis and treatment of PKD.
    Grantham JJ
    Nephrol News Issues; 2006 Aug; 20(9):29-30. PubMed ID: 16916056
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic interventions for autosomal dominant polycystic kidney disease.
    Edelstein CL
    Nephrol News Issues; 2008 Mar; 22(3):25-6. PubMed ID: 18372677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autosomal dominant polycystic disease.
    Pedrolli C; Cereda E
    Hepatology; 2009 Nov; 50(5):1671-2. PubMed ID: 19876943
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of VEGF polymorphism on progression of autosomal dominant polycystic kidney disease.
    Reiterová J; Obeidová H; Lenícek M; Stekrová J; Merta M; Maixnerová D; Vítek L; Viklický O; Tesar V
    Kidney Blood Press Res; 2008; 31(6):398-403. PubMed ID: 19060482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human anti-mouse antibodies interferences in Elecsys PTH assay after OKT3 treatment.
    Cavalier E; Carlisi A; Chapelle JP; Orfanos P; Uzan M; Falque V; Delanaye P; Hachicha M
    Transplantation; 2009 Feb; 87(3):451-2. PubMed ID: 19202453
    [No Abstract]   [Full Text] [Related]  

  • 8. Rituximab to treat active SLE in a hemodialysis patient.
    Nadri QJ
    Saudi J Kidney Dis Transpl; 2009 Nov; 20(6):1085-6. PubMed ID: 19861879
    [No Abstract]   [Full Text] [Related]  

  • 9. Diabetes leading cause of kidney failure.
    Stropp C
    Aust Nurs J; 2008 Jul; 16(1):35. PubMed ID: 18979660
    [No Abstract]   [Full Text] [Related]  

  • 10. Costs and consequences of ESRD in NC.
    Norman M; Young H; Bell RA
    N C Med J; 1997; 58(3):165. PubMed ID: 9164124
    [No Abstract]   [Full Text] [Related]  

  • 11. Congenital hepatic fibrosis in a child with autosomal dominant polycystic kidney disease.
    Kanaheswari Y; Hamzaini AH; Wong SW
    Med J Malaysia; 2008 Aug; 63(3):251-3. PubMed ID: 19248702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Renal insufficiency and diabetes, dietetic management].
    Dousseaux MP
    Soins; 2006 Mar; (703 Suppl 1):1S26-7. PubMed ID: 16604815
    [No Abstract]   [Full Text] [Related]  

  • 13. Rate of undiagnosed diabetes raises questions.
    Ho S
    Nephrol News Issues; 2006 Aug; 20(9):31. PubMed ID: 16916057
    [No Abstract]   [Full Text] [Related]  

  • 14. Relationship between chronic kidney disease prevalence and end-stage renal disease risk.
    Hallan SI; Vikse BE
    Curr Opin Nephrol Hypertens; 2008 May; 17(3):286-91. PubMed ID: 18408480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rhombencephalosynapsis associated with autosomal dominant polycystic kidney disease Type 1.
    Elliott R; Harter DH
    J Neurosurg Pediatr; 2008 Dec; 2(6):435-7. PubMed ID: 19035693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous bilateral native nephrectomy and living donor renal transplantation are successful for polycystic kidney disease: the University of Maryland experience.
    Kramer A; Sausville J; Haririan A; Bartlett S; Cooper M; Phelan M
    J Urol; 2009 Feb; 181(2):724-8. PubMed ID: 19091353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic kidney disease in the context of cardiovascular disease: a brief overview.
    Nichols N
    Can J Cardiovasc Nurs; 2008; 18(3):6-11. PubMed ID: 18727281
    [No Abstract]   [Full Text] [Related]  

  • 18. Systemic lupus erythematosus with generalized chronic cutaneous (discoid) lupus erythematosus.
    Dadlani C; Pulitzer M; Prystowsky SD
    Dermatol Online J; 2008 May; 14(5):5. PubMed ID: 18627741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatolithiasis in a patient with autosomal dominant polycystic kidney disease treated by extracorporeal shock wave lithotripsy (ESWL).
    Lee JY; Dong SH; Woo YS; Jang JY; Kim HJ; Kim BH; Chang YW; Chang R
    Dig Liver Dis; 2009 Aug; 41(8):609. PubMed ID: 18804422
    [No Abstract]   [Full Text] [Related]  

  • 20. [Biliptysis as the initial symptom of a rare complication of autosomal dominant polycystic kidney disease].
    Capote Pereira LL; Montero Ferrer S; Mera Fernández AE; Capote Leyva E; Pozo Calderón M; Artimes Hernández Y
    Nefrologia; 2008; 28(5):564-5. PubMed ID: 18816223
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.